The horrific bombing yesterday in Boston shocked people nationwide and sent investors from the market as they tried to figure out what happened and whether there was more in store...
Keep Reading →
April 16 - News
Yesterday's combination of horrible news, including the tragic explosion in Boston and troubling concerns on the economic front, left investors shaken.
Keep Reading →
April 16 - News
Editor's Note: Related tickers: Berkshire Hathaway Inc. (NYSE:BRK.A), American International Group, Inc.
Keep Reading →
April 15 - Hedge Funds
The S&P 500 (INDEXSP:.INX) and the narrower, price-weighted Dow Jones Industrial Average (INDEXDJX:.DJI) just recorded their best weekly performances of the year.
Keep Reading →
April 15 - News
Editor's Note: Related tickers: Colgate-Palmolive Company (NYSE:CL), The Gap Inc.
Keep Reading →
April 15 - Hedge Funds
You would think that the medical-device sector would be rife with big gainers thanks to an aging population, but it's not quite as simple as that.
Keep Reading →
April 14 - Hedge Funds
Dividend stocks are everywhere, but many just downright stink. In some cases, the business model is in serious jeopardy, or the dividend itself isn't sustainable.
Keep Reading →
April 14 - News
A full 23 months ago, I started identifying 10 companies that I would be putting $40,000 of my own retirement money behind.
Keep Reading →
April 13 - News
The world's oldest annual marathon gets under way this weekend. It's a big event for the runners, but it's also a huge one for the city of Boston and numerous companies.
Keep Reading →
April 13 - News
Several weeks after the end of each quarter, hedge funds and other major investors are required to file 13Fs with the SEC.
Keep Reading →
April 11 - Hedge Funds
I had recommended staying away from the company for now because it looked too risky with a long wait before the company could complete its second phase 3 trial for pimavanserin...
Keep Reading →
April 11 - News
There are several factors that could hurt other stocks that shouldn't be an issue for Johnson & Johnson (NYSE:JNJ). For example.
Keep Reading →
April 11 - News
The Dow Jones Industrial Average isn't just for industrial stocks anymore.
Keep Reading →
April 10 - News
Johnson & Johnson (NYSE:JNJ) announced on Monday that it had received a third Breakthrough Therapy Designation for the blood cancer drug ibrutinib that it's developing with Pharmacyclics...
Keep Reading →
April 10 - News
Despite trading lower for most of the morning, the markets made an about-face around 2 p.m. ET, and the three major indexes all closed higher.
Keep Reading →
April 9 - News
After spending most of the day in negative territory, the Dow Jones Industrial Average (INDEXDJX:.DJI) made a late run to finish up 48 points or 0.3% as optimism about the beginning...
Keep Reading →
April 9 - News
Earnings season is back, with weeks of quarterly reports on tap for Wall Street to pick apart and analyze.
Keep Reading →
April 8 - News
Johnson & Johnson (NYSE:JNJ) was in 67 hedge funds' portfolio at the end of December. JNJ has experienced a decrease in hedge fund interest in recent months.
Keep Reading →
April 8 - News
Targeting psoriasis, rheumatoid arthritis, and other immune diseases has created some massive markets over the last decade.
Keep Reading →
April 8 - News
Despite making some progress to recoup losses on Friday, the Dow Jones Industrial Average is back in a downward dip this morning.
Keep Reading →
April 8 - News
Alcoa Inc (NYSE:AA) will provide the informal kickoff to first-quarter earnings season Monday afternoon as the first Dow Jones industrial average component to report figures ...
Keep Reading →
April 8 - News
Recently, investors have started worrying a lot more that the stock market's rally has come too far too fast.
Keep Reading →
April 8 - News
Looking for a cheap stock with name-brand power and a strong, diversified portfolio of products? At first glance, you couldn't do much better than Abbott Laboratories (NYSE:ABT...
Keep Reading →
April 8 - News
Most companies talk a good game when it comes to promoting their futures. But some companies do a better job than others in putting their money where their mouths are.
Keep Reading →
April 8 - News
Warren Buffett knows what he likes -- and he gets what he likes.
Keep Reading →
April 7 - News
Before there was even a fancy term like "nicotine replacement therapy," the Swedish were using nicotine gum in the 1960s to help royal navy submariners manage their nicotine cravings...
Keep Reading →
April 7 - News
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
April 7 - News
Investors received a rude awakening on April 5, when the government released its March payroll data—and the outcome wasn’t good. U.S.
Keep Reading →
April 7 - News
With the SPDR S&P Biotech Index up 22% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
April 7 - News
Editor's Note: Related tickers: Citigroup Inc.
Keep Reading →
April 4 - Hedge Funds
Despite the fact that it is a consumer staple stock (with a beta of 0.3), The Procter & Gamble Company (NYSE:PG) has outperformed the S&P 500 over the last year with the stock...
Keep Reading →
April 4 - Stock Analysis
There might be economic gloom on the horizon enough to send the Dow Jones Industrial Average (Dow Jones Indices:.DJI) tumbling 111 points, but Merck & Co., Inc.
Keep Reading →
April 4 - News
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
April 3 - News
The drug, Invokana, the very first of its kind, was given the okay after nine clinical trials involving more than 10,000 patients with Type 2 diabetes.
Keep Reading →
April 2 - News
It's been almost 23 months since I introduced the World's Greatest Retirement Portfolio to Foolish readers.
Keep Reading →
April 2 - News
Blackrock Advisors Llc is a giant fund manager with $95 billion worth of assets under management.
Keep Reading →
April 1 - News
I haven't ever heard him say it directly, but it's pretty clear that Warren Buffett has no interest in buying biotech companies.
Keep Reading →
March 31 - Hedge Funds
Both the Dow Jones Industrial Average 2 Minute (INDEXDJX:.DJI) and the S&P 500 (INDEXSP:.INX) finished March at new all-time record highs.
Keep Reading →
March 31 - News
If you were looking to build a portfolio based on the hits of pop stars, what stocks would interest such stars? In this article, we'll consider some hypothetical stock picks from...
Keep Reading →
March 30 - News
Recently, with the loss of patents causing generic competition, the main attraction to pharmaceutical companies has been their dividend.
Keep Reading →
March 29 - News
Wall Street brokers and hedge fund managers are generally known to underperform the market.
Keep Reading →
March 28 - News
The broad-based S&P 500 (S&P Indices:.INX) may be having one heck of a time trying to eclipse its previous all-time high, but that hasn't stopped a breathtaking 54% of companies...
Keep Reading →
March 28 - News
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Keep Reading →
March 27 - News
Few big biotech firms have been as successful recently as Celgene Corporation (NASDAQ:CELG).
Keep Reading →
March 26 - News
For the last several years, Merck & Co., Inc.
Keep Reading →
March 26 - News
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.
Keep Reading →
March 26 - News
Pfizer Inc. (NYSE:PFE) is the largest healthcare company in the world in terms of market capitalization.
Keep Reading →
March 26 - News
The biotech sector is perhaps the most volatile and risk-prone sector in the market, but investors still love it.
Keep Reading →
March 26 - News
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
March 25 - News
